SCHEMBL23919290

SCHEMBL23919290

CCc1ccc2c(oc3ccccc32)c1N(c1ccccc1)c1cc(C(C)C)c2ccc3c(N(c4ccccc4)c4c(CC)ccc5c4oc4ccccc45)cc(C(C)C)c4ccc1c2c43

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GAA P10253 1/20 0.32
ALOX5 P09917 1/20 0.32
CYP19A1 P11511 2/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CYP17A1 P05093 1/20 0.31
TNKS O95271 1/20 0.31
PARP1 P09874 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
PARP2 Q9UGN5 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919295 0.93 ALOX5 (0.31) ALOX5CYP1A2
SCHEMBL23919292 0.92 TP53 (0.32) KMT2AMEN1SMN1; SMN2ALOX5ALDH1A1
SCHEMBL23919294 0.92 MEN1 (0.30) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL23919293 0.90 MEN1 (0.30) KMT2AMEN1
SCHEMBL23919467 0.89 PRKDC (0.32) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL23919291 0.89 TP53 (0.33) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL21686948 0.87 MEN1 (0.32) KMT2AMEN1CNR2GPR55
SCHEMBL4084424 0.84 ALOX5 (0.32) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL21940441 0.83 MEN1 (0.30) KMT2AMEN1
SCHEMBL23919472 0.82 ALOX5 (0.32) ALOX5CYP1A2PRKDCATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 KMT2A 236/4885MEN1 2129/4885NPC1 3340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.